Stock Taper
OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS
KRSA
KORSANA BIOSCIENCES, INC.
NASDAQ
$34.99
▲ UP 3.77% (1.27)

KEY STATISTICS

Market Cap$163.80 M
52w High$59.36
52w Low$7.19
Dividend Yield—
Frequency—
P/E-20.83
Volume33.66K
Shares Out.4.68M

COMPANY

LEADERSHIP

Jonathan Violin
CHIEF EXECUTIVE
Jonathan Violin

COMPENSATION 2026

Salary$390,831
Stock Awards$323,665
Incentive Plan Pay$0
All Other Comp.$35,327
Total$874,823

ABOUT

SECTOR
Healthcare
WENT PUBLIC
September 9, 2026
METHOD OF GOING PUBLIC
Reverse Merger
FULL TIME EMPLOYEES
1

PRICE TARGET

Target High$55.00
Target Low$43.00
Target Median$49.00
Target Consensus$49.00

UPCOMING EARNINGS

DateNov 11, 2026
DayWednesday
Rev. Est.—
NOV
11
WED

SPLIT RECORD

DATETYPERATIO
2026-09-09Reverse1:7
2023-05-16Reverse1:20

PRICE

$34.99 ▲ UP 3.77% (+$1.27)
OVERLAYS
$33.00$34.00$35.009:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM34.99

About Korsana Biosciences, Inc.

https://korsana.com ↗

Cyclerion Therapeutics, Inc., a Cambridge-based clinical-stage biopharmaceutical company founded in 2018, develops sGC stimulator therapeutics to enhance cyclic GMP production.

INDUSTRY

Biotechnology

A PRODUCT KORSANA BIOSCIENCES, INC. IS KNOWN FOR

KRSA-028
KRSA-028

KRSA-028 is a clinical-stage antibody targeting Alzheimer's disease, developed with Korsana's THETA™ platform to enhance delivery across the blood-brain barrier.

COMPETITORS

COMPETITOR
ALEC COMPARE
BIIB COMPARE
DNLI COMPARE
LLY COMPARE
PRTA COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
4
LISTED HERE
2
RANKED BY POSITION SIZE
ONEQ
0.00% · 3.0K
DFSU
0.00% · 474

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book2
Overall Score1

INSIDER TRADES

★
OFFICER: CHIEF FINANCIAL OFFICER
Vignola Mark J.
— · 394.3K shares
2026-09-08
★
OFFICER: CHIEF MEDICAL OFFICER
Leoni Matthew James
— · 253.4K shares
2026-09-08
★
DIRECTOR
Shah Nimish P
— · 1.9M shares
2026-09-08
★
DIRECTOR
Pernice Michelle Patricia
Purchase · 48.4K shares
2026-09-09

SECTORS PEERS

PEERPRICE
XTLB$2.37COMPARE
KTTA$0.52COMPARE
QNRX$7.06COMPARE
PLRZ$10.99COMPARE
ADXN$3.40COMPARE
TCRT$1.20COMPARE
RADX$1.65COMPARE